The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010
about
Minimally Invasive Versus Open Total Gastrectomy for Gastric Cancer: A Systematic Review and Meta-analysis of Short-Term Outcomes and Completeness of Resection : Surgical Techniques in Gastric CancerAdjuvant and/or neoadjuvant therapy for gastric cancer? A perspective reviewThe optimal extent of gastrectomy for middle-third gastric cancer: distal subtotal gastrectomy is superior to total gastrectomy in short-term effect without sacrificing long-term survival.Pathogenic roles of alterations in vitamin D and vitamin D receptor in gastric tumorigenesisOptimal duration of fluorouracil-based adjuvant chemotherapy for patients with resectable gastric cancer.Expression of the γ-phosphorylated histone H2AX in gastric carcinoma and gastric precancerous lesionsAssociation of IL-17 polymorphisms with gastric cancer risk in Asian populationsBevacizumab plus capecitabine and cisplatin in Chinese patients with inoperable locally advanced or metastatic gastric or gastroesophageal junction cancer: randomized, double-blind, phase III study (AVATAR study).Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study.Phase I dose-escalation study of aflibercept in combination with docetaxel and cisplatin in patients with advanced solid tumoursCediranib with mFOLFOX6 vs bevacizumab with mFOLFOX6 in previously treated metastatic colorectal cancerThe Oncological Value of Omentectomy in Gastrectomy for Cancer.The postoperative component of MAGIC chemotherapy is associated with improved prognosis following surgical resection in gastric and gastrooesophageal junction adenocarcinomasAflibercept in the treatment of patients with metastatic colorectal cancer: latest findings and interpretations.A long non-coding RNA signature to improve prognosis prediction of gastric cancer.Surgical Outcomes Associated with Operable Gastric Cancer in a Tertiary Care Indian Hospital.Integration of radioembolisation into multimodal treatment of liver-dominant metastatic colorectal cancer.Beyond bevacizumab: new anti-VEGF strategies in colorectal cancer.Targeted approach to metastatic colorectal cancer: what comes beyond epidermal growth factor receptor antibodies and bevacizumab?Long-term survival after gastrectomy for cancer in randomized, controlled oncological trials: comparison between West and East.Angiogenesis in esophageal and gastric cancer: a paradigm shift in treatment.MRI of the stomach: a pictorial review with a focus on oncological applications and gastric motility.Surgical techniques, open versus minimally invasive gastrectomy after chemotherapy (STOMACH trial): study protocol for a randomized controlled trial.Bradykinin Promotes Cell Proliferation, Migration, Invasion, and Tumor Growth of Gastric Cancer Through ERK Signaling Pathway.Short-term outcomes in minimally invasive versus open gastrectomy: the differences between East and West. A systematic review of the literature.Comprehensive profiling of virus microRNAs of Epstein-Barr virus-associated gastric carcinoma: highlighting the interactions of ebv-Bart9 and host tumor cells.Early postoperative tumor marker responses provide a robust prognostic indicator for N3 stage gastric cancer.Therapeutic strategy in unresectable metastatic colorectal cancer.Antiangiogenesis therapy in the treatment of metastatic colorectal cancer.International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus.A pilot study to investigate the role of thymidylate synthase as a marker of prognosis for neoadjuvant chemotherapy in gastric and gastro-oesophageal junction adenocarcinoma.Modified DCF (mDCF) regimen seems to be as effective as original DCF in advanced gastric cancer (AGC).What studies are appropriate and necessary for staging gastric adenocarcinoma? Results of an international RAND/UCLA expert panel.The correlation between pre-operative serum tumor markers and lymph node metastasis in gastric cancer patients undergoing curative treatment.Chemotherapy treatment patterns and neutropenia management in gastric cancer.Usefulness of the log odds of positive lymph nodes to predict and discriminate prognosis in gastric carcinomas.Antiangiogenic therapy--evolving view based on clinical trial results.A Phase I study of cabazitaxel in patients with advanced gastric cancer who have failed prior chemotherapy (GASTANA).Colon Metastasis, 8 years after Gastrectomy, for Stage I Gastric Cancer.Optimal reconstruction methods after distal gastrectomy for gastric cancer: A systematic review and network meta-analysis.
P2860
Q26782547-1B3E8681-DBBE-47DB-927D-528E179C97FDQ28088619-FEBC2094-12A6-4F1D-A95C-61EE1DDDA1DCQ33706928-41283183-F9F6-466E-84A6-B0D2FB57AA8FQ33710174-86CAEEF5-B7C8-46F2-BFE2-CB7D08A7C690Q35080220-B7E93F11-D19C-4A5A-BA98-99A0ACCFBB8FQ35167578-236285A6-A3EA-47E5-8A56-2213642E2F8FQ35594303-7CF9A2BB-F930-469F-ABE4-5CD91FB8236FQ35981433-EB854BE1-F2F3-435C-8791-89EEBEF19FA6Q36117215-E4AD9AA4-6EDF-410D-89C8-3A59A41762D2Q36166808-07DD250F-33D7-42D9-8C39-9DF2325073CAQ36671812-E2B498D1-8700-4960-9B6A-8CA1A0AD2254Q36849794-8E3D1DD8-246F-477C-B4F6-45F853C9EC66Q37217887-67F341AC-D81A-481B-8FC8-43F3E8D0EF02Q37255848-4CDEA9F7-8510-4786-A57F-7BCEF18C4080Q37268013-33357DF0-2E6C-4D1E-AAD4-38E9415F84FFQ37717193-A64F608B-2B71-4B1B-9DB5-25E0996E7A6CQ37996428-3BAB5DC3-0328-4695-9FA5-BBE0F4B544FDQ38011768-CE291BB3-DBEA-4379-B7CF-B34A1E77241EQ38074430-E9241AEF-A8F5-4303-BA9F-775F101884D3Q38076028-DD969631-53F8-4F55-8879-35B2E7F94F57Q38216461-D369FF42-F390-4675-88EB-BCC87019F033Q38254792-F31A1BD0-9D6B-4784-9D2D-1A3F709B6075Q38413316-966F1A66-A74E-4A12-840C-0920C32EFD31Q38808634-B920BB09-FD75-4D82-B8C8-6C9181EC2B23Q39449636-BD130663-2DF1-4FCD-B01A-BA9362CFF8CBQ40769652-B4A49B0B-8565-4E52-9CB8-1A5745C97371Q41390145-005F37AA-7E21-4CFB-B188-085D58691ECBQ42000639-978730CB-5C1B-460A-9B38-52C85731681BQ42402968-E43B0E99-800E-4954-BA10-76E1734FDEA4Q42465120-F8835D7B-9DA7-467C-A4C1-4A9F41301F80Q43223220-688CE034-0B8C-43FE-9D9B-E2F01A7D0AA3Q43872716-D369F116-8191-4B24-AC12-5249D5852AF4Q44838582-2B6FEFC8-2A1C-455D-A213-F2CC31754F10Q45394744-53ECBB08-060A-495C-9DE0-0B464BFCD094Q46057636-6BCCDBF8-50B1-49C4-9360-6E6C73AA4378Q53652687-A9444D40-FBF8-4AB2-80E2-9E2FA5443D44Q53664329-2FA82060-EE59-422B-91E3-17B92D482DF1Q53673558-6AFE65D8-C68C-4099-A1F8-9B86DB14E34DQ53726515-64B7BF5C-F65B-423A-9F7B-B4ACE5F3011AQ55209464-F4CE740C-FEC4-4114-ACA0-5D4ACA92DC2A
P2860
The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010
description
article
@en
im Juni 2011 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в червні 2011
@uk
name
The diagnosis and management o ...... stinal Cancer, Barcelona, 2010
@en
The diagnosis and management o ...... stinal Cancer, Barcelona, 2010
@nl
type
label
The diagnosis and management o ...... stinal Cancer, Barcelona, 2010
@en
The diagnosis and management o ...... stinal Cancer, Barcelona, 2010
@nl
prefLabel
The diagnosis and management o ...... stinal Cancer, Barcelona, 2010
@en
The diagnosis and management o ...... stinal Cancer, Barcelona, 2010
@nl
P2093
P2860
P50
P356
P1433
P1476
The diagnosis and management o ...... stinal Cancer, Barcelona, 2010
@en
P2093
A Cervantes
B D Minsky
B Nordlinger
C Van de Velde
P2860
P356
10.1093/ANNONC/MDR284
P433
Supplement 5
P478
22 Suppl 5
P577
2011-06-01T00:00:00Z